The place of ARBs in heart failure therapy: is aldosterone suppression the key?

Since the launch of the first orally available angiotensin II (AngII) type 1 receptor (AT(1)R) blocker (ARB) losartan (Cozaar) in the late 1990s, the class of ARBs (or ‘sartans’, short for Angiotensin-RecepTor-ANtagonistS) quickly expanded to include candesartan, eprosartan, irbesartan, valsartan, t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Cardiovasc Dis
Egile Nagusiak: Markan, Uma, Pasupuleti, Samhitha, Pollard, Celina M., Perez, Arianna, Aukszi, Beatrix, Lymperopoulos, Anastasios
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2019
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6691655/
https://ncbi.nlm.nih.gov/pubmed/31401939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944719868134
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak